Propofol causes neuronal degeneration in neonatal mice and long-term neurocognitive consequences in adult mice by Li, Pei-Xing et al.
Li et al 
Trop J Pharm Res, September 2016; 15(9): 1889  
 
Tropical Journal of Pharmaceutical Research September 2016; 15 (9): 1889-1896 
ISSN: 1596-5996 (print); 1596-9827 (electronic) 
© Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria.  
All rights reserved. 
 
Available online at http://www.tjpr.org 
http://dx.doi.org/10.4314/tjpr.v15i9.11 
Original Research Article 
 
 
Propofol causes neuronal degeneration in neonatal mice 
and long-term neurocognitive consequences in adult mice 
 
Pei-Xing Li1, Feng Ru1, Yan-Min Lu2 and Lei Zhang1* 
1Department of Anesthesia, 2Department of Stomatology, Linzi District People’s Hospital, Zibo, Shandong 255400, China 
 
*For correspondence: Email: zhangleizler@hotmail.com; Tel/Fax: 0086-533-7180469 
 
Received: 24 March 2016        Revised accepted: 18 August 2016 
 
Abstract 
Purpose: To investigate the effect of propofol on brain development in neonatal mice and long-term 
neurocognitive impact in adult mice.  
Method: The offspring of female C57Bl/6 and male CD-1 mice were administered propofol at 
concentrations of 2.5 and 5.0 mg/kg (treatment group) or normal saline (control) on postnatal day 7. 
Thereafter, histological and immunohistochemical examinations were performed on the mice brain. 
Apoptotic assay, neuronal nuclei antigen immunohistochemistry (to assess neuron density), and 
behavioral and neurocognitive tests were conducted on the adult mice.  
Results: Propofol induced cellular degeneration and apoptosis in the brains of neonatal mice. It also 
modulated physiological parameters (pH, PO2, glucose and lactate), among which decreased blood 
glucose might be associated with cellular degeneration in the brain. Propofol also caused long-term 
neuronal deficits in adults, which showed impaired neurocognitive functions. Upon reaching adulthood, 
propofol-treated mice showed slow learning response and poor memory compared to controls.  
Conclusion: Propofol causes neurodegeneration in neonatal mice and has long-term neurocognitive 
consequences in adults, indicating that the use of propofol anesthetics in neonates requires careful 
consideration. 
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Several classes of anesthetic and sedative 
agents, such as benzodiazepines, barbiturates, 
ketamine, propofol, and etomidate, have been 
used in infants and children. These anesthetics 
act mainly by blocking N-methyl-D-aspartate 
(NMDA) receptors and/or enhancing γ-
aminobutyric acid A (GABAA) receptors at 
various rates [1]. These anesthetic agents have 
been shown to cause extensive neuronal 
apoptosis, and neuronal degenerative and 
morphological changes in neonatal rodents, and 
subsequent abnormalities in learning and 
behavior in adults [2–7]. Propofol (chemically, 
sodium thiopental, or Pentothal) is a commonly 
used substance for the induction of anesthesia, 
with more rapid recovery than other anesthetics. 
It has thus become widely used as an 
intravenous anesthetic, although it has been 
shown to induce neurocognitive dysfunction in 
adults. It has also been reported to induce 
apoptosis by acting as an NMDA and GABAA 
agonist and Na+ channel blocker [3,8,9]. In 
addition, it impairs cell proliferation and inhibits 
neurogenesis in the brains of immature mice, 
possibly also inducing cognitive dysfunction [10].  
 
However, propofol has also been found to play 
protective roles in hypoxic brains of rats by 
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maintaining metabolism, such as lowering arterial 
blood flow and intracranial pressure [11-13]. It 
reportedly protects the central nervous system by 
modulating the intracellular oxidative state 
through the GABA and NMDA receptors [14-17]. 
Thus, the roles of such neurotransmitter 
receptors remain important when considering the 
use of anesthetics. However, the expression 
patterns of these neurotransmitter receptors 
significantly differ in the brains of adults and 
newborns [9,18] and thus there is significant 
interest in the cellular mechanisms of general 
anesthetic agents and their effects on the 
postnatal development of the brain [19]. 
 
In this study, we investigated the effects of 
propofol administration on the brains of 
developing mice and elucidated its long-term 
consequences in adult mice in terms of 




Experimental animals and propofol treatment 
 
Ethical approval for the animal experiments was 
obtained from the Institutional Animal Ethical 
Committee of Linzi District People’s Hospital, 
Zibo, Shandong, China (REF/IAEC/14-15/2198). 
The protocols for the animal experiments were 
approved by this committee and conducted in 
accordance the Guide for the Care and Use of 
Laboratory Animals, National Research Council 
(US) Committee for the Update of the Guide for 
the Care and Use of Laboratory Animals [20]. 
Female C57Bl/6 and male CD-1 mice were 
housed under controlled conditions at 22–24 °C 
and 50–60 % humidity, with a 12 h light/dark 
cycle. The offspring of these mice, on postnatal 
day 7 (P7), were randomly divided into three 
groups: normal saline (NS; controls; n = 20), 
propofol 2.5 mg/kg body weight (Prop 2.5; n = 5, 
and propofol 5.0 mg/kg body weight (Prop 5.0; n 
= 30). All injections were administered 
intraperitoneally, and then all mice were allowed 
to develop to adulthood (10 weeks old). 
 
Analysis of respiratory and metabolic factors  
 
Mice in the control group and Prop 5.0 group (n = 
5, each group) were used to analyze respiratory 
and metabolic functions at intervals of 3, 6, and 
12 h. Temporal profiles were established for the 
physiological variables, and arterial blood from 
mice in the anesthesia group was collected at 3, 
6, and 12 h. The blood from the mice was 
aspirated through the right carotid artery and the 
levels of pH, PCO2, PO2, glucose, and lactate 
were estimated using an SMARTTM analyzer (i-
Stat Corp., East Windsor, NJ, USA).  
Histological examination 
 
At P7, 12 mice (3 from each group) were 
exposed to 12 h of either NS (controls) or 
propofol (each treatment group). Then they were 
sacrificed and their brains were excised for 
histological examination by staining with 
hematoxylin and eosin (HE). Hippocampal 
sections of the brain were fixed in 0.1 % 
methanol, dehydrated, and embedded in wax. 
These were sliced to 5 mm thickness and stained 
with H&E in the conventional manner. Stained 
slides were observed under a light microscope 
(40×) and photographed to examine 
morphological changes in the CA1 and CA3 




At P7, 12 more mice (3 from each group) were 
exposed to either NS (controls at interval of 12 h) 
or propofol (5.0 mg/kg at intervals of 3, 6, and 12 
h). Then they were sacrificed and their brains 
were excised for immunohistochemical (IHC) 
analyses of apoptosis. The brains were fixed in 4 
% paraformaldehyde. Then, 40 µm sections were 
cut and blocked on glass slides using 3 % H2O2. 
These were incubated with anti-activated 
caspase-3 (C-3A) antiserum (Cell Signaling 
Technology, Beverly, MA, USA) at 1:500 dilution. 
The primary antibody-labeled sections were 
treated with horseradish peroxidase-labeled anti-
rabbit secondary antibody (Dako, Glostrup, 
Denmark) followed by visualization using 
diaminobenzidine chromogen (Dako). Slides 
were counterstained with hematoxylin, and 
caspase-3-positive regions were visualized under 
a light microscope (40×) and photographed. The 
C-3A-positive cells in brain sections (per mm2) 
were scored; data are presented as the 
percentage of C-3A-positive cells compared to 
controls.  
 
TUNEL assay  
 
The terminal deoxynucleotidyl transferase dUTP 
nick end labeling (TUNEL) assay is an indicator 
of cellular apoptosis. The in situ cell death 
detection kit (Roche Diagnostics, Basel, 
Switzerland) was used for the TUNEL assay as 
per the manufacturer’s instructions. At P7, 12 
more mice (3 controls and 5 Prop 5.0 mice) were 
exposed to 12 h of NS (controls at interval of 12 
h) or propofol (5.0 mg/kg at intervals of 3, 6, and 
12 h). Then they were sacrificed and their brains 
were excised for TUNEL staining. Briefly, fixed 
paraffin-embedded brain tissues were 
deparaffinized and rehydrated. Then the slides 
were blocked with 5 % bovine serum albumin 
and 20 % normal bovine serum in 0.1 M Tris-
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HCl, pH 7.5. The sections were washed with 
phosphate-buffered saline and subjected to end 
labeling with digoxigenin-11-deoxyuridine 
triphosphate using the terminal deoxynucleotidyl 
transferase enzyme. Then the labeled sections 
were treated with stop-wash buffer and incubated 
with 4′-6-diamidino-2-phenylindole. The TUNEL-
positive regions were observed under a light 
microscope (40×) to score TUNEL-positive cells 
in brain sections (per mm2); data are presented 
as the percentage of positive cells compared to 
controls.  
 
RNA isolation and quantitative real-time 
polymerase chain reaction 
 
Hippocampal slices (n = 3, each group) were 
used for RNA isolation and analysis of the 
expression of genes involved in apoptotic 
pathways. Total RNA from brains was isolated 
using Trizol reagent (Invitrogen, Waltham, MA, 
USA) and reverse-transcribed to obtain cDNA 
using the Reverse Transcriptase Superscript III 
kit (Invitrogen), in accordance with the 
manufacturer’s instructions. Quantitative real-
time polymerase chain reaction (qPCR) was 
performed with TaqMan Universal PCR mix and 
TaqMan minor groove binder probes labeled with 
6-carboxyfluorescein dye on an ABI 7500 Real 
Time PCR System (Applied Biosystems, Foster 
City, CA, USA). The specific primer sets for 
caspase-3, caspase-9, and PARP genes were 
used for qPCR. Relative quantification of mRNA 
was performed by normalizing its level to that of 
18s RNA. 
 
Long-term cellular and neurocognitive impact 
analysis  
 
The effects of propofol on long-term 
neurocognition were analyzed in 5 Prop 5.0 
mice. After treatment, the animals were kept in 
chambers and allowed to develop until P28. 
Then they were separated by sex and placed in 
different chambers. The neurocognitive tests 
started at 10 weeks of age, after which the mice 
were sacrifice; their brains were excised and 





The NeuN protein is specific to neurons and 
localized in the nuclei of post-mitotic neurons and 
perikarya. NeuN IHC staining was performed on 
the brains of adult mice (n = 3, each group) after 
perfusion with chilled 0.9 % NS and 4 % 
paraformaldehyde. Paraffin-embedded brain 
sections (40 µM) were rehydrated in graded 
alcohol followed by washing with Tris-buffered 
saline Tween-20. Then the sections were 
incubated with primary NeuN antibody 
(Chemicon, Billerica, MA, USA) at 1:100 dilution 
overnight, followed by incubation with donkey 
anti-mouse IgG secondary antibody (Cell 
Signaling Technology) for 3 h. The density of 
NeuN-stained neurons was determined using a 
laser-scanning confocal microscope (Nikon, 
Tokyo, Japan). NeuN-stained neurons were 
examined in the CA3 pyramidal cell layer of the 
hippocampus and retrosplenial cortex regions 
adjacent to the brain midline. The data are 
quantitatively expressed as raw neuronal density 
counts and percentage NeuN expression, for 
comparison between the propofol-treated and 
control groups. 
 
Behavioral observations and neurocognitive 
testing 
 
The Morris Water Maze (MWM) test has been 
widely used to analyze spatial learning and 
memory in behavioral neuroscience, as 
described elsewhere [21]. Prior to this test, 
offspring were kept together in groups from the 
same dam up to P28. For the MWM test, a pool 
(100 cm diameter × 50 cm depth) with black 
internal coating was filled with water (27 °C) and 
a camera was placed 2.5 m above it. The pool 
was divided into four quadrants: northwest (NW), 
northeast (NE), southwest (SW), and southeast 
(SE). Spatial learning was examined using an 
escape platform (10 cm diameter) placed in the 
second quadrant (submerged at a depth of 2 cm; 
25 cm from the edge). Mice were allowed to find 
the location of the platform by training four times 
per day on four successive days. Latency time 
represents the spatial learning ability in terms of 
finding the hidden platform from the start position 
(in the SE quadrant). A probe trial was performed 
to test spatial memory, starting from the start 
position on day 5 in a platform-less pool. The 
time of the first crossing of the site where the 
platform had previously been located and the 
frequency of such crossings were recorded.  
 
Statistical analysis  
 
Data are presented as mean ± standard 
deviation (SD), unless specified otherwise. Data 
were compared among groups using one-way 
analysis of variance (ANOVA) with Tukey’s post 
hoc tests for multiple comparisons. MWM test 
data were analyzed using two-way ANOVA for 
repeated measurements at different time points. 
The qPCR gene expression analysis was 
analyzed by Student’s t test. All statistical 
calculations were performed using SPSS v.17, 
and p < 0.05 was considered statistically 
significant. 
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Effects of propofol on morphological 
structures in the brains of neonatal mice 
 
 
Figure 1: Effects of propofol on the neonatal mouse 
brain. Hematoxylin and eosin-stained brain cortex 
slices from neonatal mice treated with propofol for 12 
h were analyzed under a light microscope (40×). A) 
control group; B) 2.5 mg/kg propofol; C) 5.0 mg/kg 
propofol; n = 3; scale bar = 100 µM 
 
Histological staining of brain slices was 
performed 12 h after NS or propofol exposure. 
Propofol treatment caused swelling of the 
pyramidal neurons in the CA1 region of the 
hippocampus in a dose-dependent manner 
(Figure 1). Cellular clumping and degenerative 
patches became prominent and the nuclei were 
dark and shrunken compared to controls. The 
degenerative effects of propofol on the 
morphology of brain segments also increased in 
a dose-dependent manner. Prop 5.0 mice 
showed more drastic changes in brain 
morphology, as shown by the orange-red patchy 
areas in Figure 1C, than Prop 2.5 mice. Based 
on these results, Prop 5.0 mice were used for 
further experimental analyses using different 
exposure times of anesthetic (3, 6, and 12 h). 
The 12 h exposure group was selected for further 
studies. 
 
Propofol affects respiratory and metabolic 
factors in neonatal mice 
 
Propofol exposure caused respiratory and 
metabolic imbalances in the neonatal mice, 
indicating its critical effects on early brain 
development (neurogenesis) as neurons are both 
produced in excess and also eliminated quickly 
during this critical stage of development. After 12 
h of propofol exposure, pH was significantly 
reduced compared to controls. O2 pressure was 
also significantly reduced, but CO2 pressure did 
not show a statistically significant change. 
Glucose level was significantly lower after 12 h of 
propofol treatment compared to controls, while 
lactate level was significantly higher at 12 h. 
These results indicate that propofol 
administration caused metabolic acidosis, as 
demonstrated by reduced pH, and modulated the 
levels of blood glucose and lactate (Table 1). 
 
Propofol induces cellular degeneration in the 
brains of neonatal mice  
 
Cellular degeneration in terms of cell death was 
measured using the apoptotic TUNEL assay, 
followed by C-3A IHC. TUNEL staining (Figure 
2A, C) data showed significantly increased 
staining in hippocampal (CA1 and CA3) regions 
in Prop 5.0 mice compared to controls, and there 
was a time-dependent increase in apoptosis in 
the brain: 6 %, 14 %, and 22 % at 3, 6, and 12 h 
after exposure, respectively (Figure 2C). Control 
mice showed no apoptotic staining. 
 
Table 1: Physiological factors in neonatal mice 
 
Parameter  Control (n=5) Propofol (n=5) 
0 h 12 h 3 h 6 h 12 h 
pH  7.36±0.03 7.28±0.04 7.31±0.02 7.21±0.03 7.08±0.02* 
PCO2 (mmHg) 54±7 50±6 48±4 51±5 55±5 
PO2 (mmHg) 146±4 141±3 144±5 128±4 116±3* 
Glucose (mg/dL) 134±8 108±6 114±6 96±7 82±5* 
Lactate (mmol/L) 2.8±0.3 3.6±0.4 4.8±0.4 5.4±0.5 6.2±0.5* 
Values are presented as mean ± standard deviation; *p < 0.05 vs. control at 12 h 
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These results were supported by the results of 
IHC staining of C-3A in cortical sections (Figure 
2D–F). Hippocampal sections of controls showed 
almost no staining, while Prop 5.0 mice showed 
increased staining in a time-dependent manner: 
4 %, 10 %, and 16 % at 3, 6, and 12 h after 
propofol treatment, respectively (Figure 2F). 
 
Propofol induces apoptosis in the brains of 
neonatal mice 
 
Propofol-induced neurodegeneration was further 
confirmed by analyzing the expression of the 
apoptosis-related genes caspase-3 and PARP 
(Figure 3). Propofol exposure caused a time-
dependent increase in caspase-3 mRNA levels. 
Specifically, it caused 1.2-, 1.4-, and 1.6-fold 
increases in caspase-3 levels at 3, 6, and 12 h 
after exposure. Comparing the gene expression 
data to those in the 12 h control, propofol 
increased caspase-3 mRNA levels by 1.3-fold (p 
< 0.05) and 1.8-fold (p < 0.04) at 6 and 12 h, 
respectively. Similarly, it caused time-dependent 
increases in PARP by 1.2-, 1.4-, and 1.6-fold at 
3, 6, and 12 h. The PARP expression data 
showed statistically significant differences at 6 
and 12 h (p < 0.05 and p < 0.04). The increases 
in caspase-3 and PARP mRNA levels confirm 
the induction of apoptosis in hippocampal slices 
via activation of the apoptotic pathway. 
 
Figure 2: Effects of propofol on apoptotic cell death in brain cortical sections. A–C, TUNEL staining for apoptosis 
and quantitative expression analysis data. D–F, IHC staining for activated caspase-3 and quantitative expression 
analysis data. n = 3; scale bar 100 µM. *p < 0.05 vs. control 
 
Figure 3: Quantitative real-time polymerase chain 
reaction analysis of the apoptosis-related genes 
caspase-3 and PARP in hippocampal slices; n = 3; *p 
< 0.05; **p < 0.04 
Effects of propofol on long-term cellular and 
neurocognitive functions in mice  
 
The hippocampal CA2/3 and cortical sections of 
the brains of adult (10 weeks old) mice indicated 
vigorous cell loss in mice that were treated with 
propofol as neonates (Figure 4). NeuN 
expression in control mice demonstrated the 
presence of healthy neurons (Figure 4A), while 
decreased NeuN positivity in postembryonic 
propofol-treated mice indicated the degeneration 
of differentiated neurons (Figure 4B). The 
reduced NeuN expression (~4 %) compared to 
controls (~15 %) indicates altered functional and 
morphological developmental in the neurons of 
treated mice. 
 
Effects of propofol on behavior and learning 
of mice  
 
In terms of learning behavior, the latency time 
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Figure 4: Neuronal nuclear antigen (NeuN) 
expression pattern in cortical brain sections of adult 
mice (10 weeks old). A) control group; B) propofol-
treated group; C) NeuN expression quantification. n = 
3; scale bar, 200 µM; *p < 0.05 vs. control 
 
data showed a tendency for decreased latency 
from day 1 to day 4 in both controls and propofol-
treated mice (Figure 5). This trend in control mice 
is an indicator of normal learning. Control mice 
showed a latency time of 99.4 ± 8.6 s on day 1, 
which gradually shortened to 61.4 ± 8.2 s on day 
4. Propofol-treated mice showed almost the 
same latency time on day 1 (102.7 ± 9.4 s), but 
on day 4 it was noticeably and significantly 
longer (76.8 ± 8.6 s) than in controls. The latency 
times of propofol-treated mice on days 2, 3, and 
4 were significantly longer than in controls (p < 
0.05). Propofol treatment caused an increase in 
their latency time, reflecting a slow learning 
response compared to controls. 
 
 
Figure 5: Effects of propofol exposure on the learning 
behavior of mice analyzed by latency time (s) scoring. 
n = 3; *p < 0.05 vs. control day 1; #p < 0.05 vs. 
propofol day 1; ^p < 0.05 vs. control on the same day 
 
Next, we analyzed the effects of propofol on the 
time of first crossing of the site where a 
submerged platform had previously been located 
and the frequency of such crossings in a pool. 
The values in the control group were 42.26 ± 
11.6 s and 2.2 ± 0.92 times, respectively, and 
those in the treated mice were 58.62 ± 12.4 s 
and 1.4 ± 0.62 times, respectively (p < 0.03). The 
frequency of crossings was marginally 
significantly different (p = 0.048) between the 




The effect of propofol exposure on neuronal 
growth and brain development in neonatal mice 
was evaluated by analyzing its subsequent 
impacts on learning and memory functions in 
adulthood. Propofol caused neurodegeneration 
and induced neuronal apoptosis with 
degenerative signs in mature neurons in adult 
mice, which exhibited poor learning and memory 
behavior. Our findings suggest that propofol 
alone may not be a suitable anesthetic in clinical 
and surgical procedures for neonates. 
 
Certain adverse effects of anesthetics have been 
reported, such as the induction of 
neurodegeneration within several hours of 
exposure in neonates and impairment of 
neurocognitive performance in adulthood. The 
administration of anesthetics and sedative 
agents in rodents during synaptogenesis has 
been shown to have marked degenerative effects 
[2–7] associated with long-term neurocognitive 
deficits. The present study demonstrates that 
propofol caused cellular degeneration and led to 
long-term neuronal deficits in adulthood. Propofol 
exposure in neonatal mice induced degenerative 
signs, swelling of pyramidal neurons in the CA1 
region of the hippocampus, cellular damage, and 
degenerative structural changes in brain 
sections. It also caused cellular degeneration in 
the brain and modulated the levels of 
physiological parameters (pH, PO2, glucose, and 
lactate). However, the exact mechanisms behind 
anesthetic-induced neurotoxicity and damage to 
the neuronal signaling pathways remain unclear. 
Nonetheless, apoptotic modulation is identified 
as the main mechanism of anesthetic-mediated 
cellular responses, which further correlates with 
the activation of many cellular signaling 
components such as cell death signals, cleavage 
of cytoskeletal proteins, signaling kinases, and 
DNA repair enzymes in neuronal as well as non-
neuronal cells [3,8–10,12,22,23]. In this study, 
the activation of caspase-3, ultrastructural 
changes in the brain, and TUNEL and NeuN 
staining reflected the impacts of propofol on the 
brains of neonatal mice, causing neurotoxicity at 
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a critical developmental stage that led to long-
tern neurocognitive impacts on adult mice. C-3A 
IHC staining data confirmed these results.  
 
Anesthetics in general or at least at an excessive 
dose may have long-term effects on the 
developing brain and subsequent cognitive 
function, which must be taken into consideration 
when treating pediatric patients. Several 
anesthetics, including ketamine, midazolam, 
isoflurane, and propofol, have been reported to 
cause neurodegeneration in the developing brain 
and subsequent cognitive dysfunction in several 
animal models [2–7,10]. Propofol has also been 
reported to cause neuroapoptosis in the 
developing brain at clinically relevant 
concentrations and durations, leading to 
neurocognitive dysfunction [24,25]. In terms of 
the impact of propofol on long-term cellular and 
neurocognitive functions in neonatal mice, we 
found vigorous cell loss and hindered cognitive 
performance in propofol-treated mice in 
adulthood compared to controls. 
 
We propose that propofol may inhibit amino acid 
neurotransmitters such as aspartate, glutamate, 
glycine, and GABAA, because these 
neurotransmitters play a central role in 





Propofol exposure causes neurodegeneration in 
the brains of neonatal mice, leading to learning 
and behavioral deficits in adults. Its effects may 
be due to the lowering of blood glucose levels as 
well as the release of amino acid 
neurotransmitters. Overall, our findings indicate 
the need for careful consideration prior to the use 
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